Masong, Daylinda B.

HRN: 11-78-95  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/15/2023
CEFUROXIME 500MG (TAB)
09/15/2023
09/22/2023
PO
500mg
BID
S/P D&C
Waiting Final Action 
09/20/2023
CEFUROXIME 1.5GM (VIAL)
09/20/2023
09/21/2023
IV
1.5gms
Q8hrs
For D&C
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: